Skip to main content
OpenTrials

Clinical trial condition

Coronary Artery Disease

Explore clinical trials studying Coronary Artery Disease. Study availability and eligibility vary by location and protocol.

3,320 public trials 447 recruiting studies
Refine in advanced search Browse all conditions

Coronary Artery Disease trial results

Completed

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-IV: (LONG-DES-IV)

NCT01186094

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +5 more
Locations
  • Stcarollo Hospital Suncheon, Cheon-nam, South Korea
  • Konyang University Hospital Daejeon, Chungcheongnam-do, South Korea
  • Wonju Christian Hospital Wŏnju, Gangwon-do, South Korea
  • Soon Chun Hyang University Hospital Bucheon Bucheon-si, Gyeonggi-do, South Korea
View Trial Details
Completed

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III (LONG-DES-III)

NCT01078038

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +5 more
Locations
  • Sam Anyang Hospital Anyang, South Korea
  • Soonchunhyang University Bucheon Hospital Bucheon-si, South Korea
  • Busan Paik Hospital Busan, South Korea
  • St.Mary's Catholic Medical Center Busan, South Korea
View all 20 locations
View Trial Details
Completed

Focal In-stent Restenosis After Drug-Eluting Stent

NCT00485004

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +6 more
Locations
  • Soonchunhyang University Bucheon Hospital Bucheon-si, South Korea
  • Choeng Ju St.Mary's Hospital Choeng Ju, South Korea
  • Kangwon National University Hospital Chuncheon, South Korea
  • Chungnam National University Hospital Daejeon, South Korea
View all 15 locations
View Trial Details
Completed

Diffuse Type In-Stent Restenosis After Drug-Eluting Stent

NCT00485030

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +6 more
Locations
  • Soonchunhyang University Bucheon Hospital Bucheon-si, South Korea
  • Choeng Ju St.Mary's Hospital Choeng Ju, South Korea
  • Kangwon National University Hospital Chuncheon, South Korea
  • Asan Medical Center Gangneung, South Korea
View all 15 locations
View Trial Details
Completed

XIENCE V: SPIRIT WOMEN Sub-study

NCT01182428

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +13 more
Locations
  • Hosital Italiano de Buenos Aires - Cardiologia Buenos Aires, Argentina
  • Instituto Cardiovascular de Buenos Aires-ICBA Buenos Aires, Argentina
  • Allgemeines Krankenhaus der Stadt Wien - Univ.Klinik f. Innere Medizin II Vienna, Austria
  • Heilig Hart Ziekenhuis Roeselare Roeselare, Belgium
View all 25 locations
View Trial Details
Completed

The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?

NCT00282711

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Disease, +8 more
Locations
  • Southwest Heart Tucson, Arizona, United States
  • Cardiology Consultants of Orange Country Medical Group, Inc Anaheim, California, United States
  • Escondido Cardiology Associates Escondido, California, United States
  • Mission Internal Medical Group Mission Viejo, California, United States
View all 43 locations
View Trial Details
Completed

Study Effect of VIA-2291 on Vascular Inflammation

NCT00358826

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +5 more
Locations
  • MIMA Century Research Associates Melbourne, Florida, United States
  • Minneapolis Heart Institute Minneapolis, Minnesota, United States
  • Cardiology Associates Research, LLC Tupelo, Mississippi, United States
  • LeBauer Cardiovascular Research Foundation Greensboro, North Carolina, United States
View Trial Details
Completed

CRESTOR Athero Imaging Head to Head IVUS Study

NCT00620542

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +6 more
Locations
  • Research Site Huntsville, Alabama, United States
  • Research Site Los Angeles, California, United States
  • Research Site Mountain View, California, United States
  • Research Site Sacramento, California, United States
View all 195 locations
View Trial Details

Related conditions